Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 151 entries
Sorted by: Best Match Show Resources per page
European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement.

Frontiers in pharmacology

van Boven JF, Tsiligianni I, Potočnjak I, Mihajlović J, Dima AL, Nabergoj Makovec U, Ágh T, Kardas P, Ghiciuc CM, Petrova G, Bitterman N, Kamberi F, Culig J, Wettermark B.
PMID: 34707502
Front Pharmacol. 2021 Oct 11;12:748702. doi: 10.3389/fphar.2021.748702. eCollection 2021.

Medication non-adherence is associated with almost 200,000 deaths annually and €80-125 billion in the European Union. Novel technological advances (smart pill bottles, digital inhalers and spacers, electronic pill blisters, e-injection pens, e-Health applications, big data) could help managing non-adherence....

Cite
van Boven JF, Tsiligianni I, Potočnjak I, et al. European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement. Front Pharmacol. 2021;12:748702doi: 10.3389/fphar.2021.748702.
van Boven, J. F., Tsiligianni, I., Potočnjak, I., Mihajlović, J., Dima, A. L., Nabergoj Makovec, U., Ágh, T., Kardas, P., Ghiciuc, C. M., Petrova, G., Bitterman, N., Kamberi, F., Culig, J., & Wettermark, B. (2021). European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement. Frontiers in pharmacology, 12748702. https://doi.org/10.3389/fphar.2021.748702
van Boven, Job Fm, et al. "European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement." Frontiers in pharmacology vol. 12 (2021): 748702. doi: https://doi.org/10.3389/fphar.2021.748702
van Boven JF, Tsiligianni I, Potočnjak I, Mihajlović J, Dima AL, Nabergoj Makovec U, Ágh T, Kardas P, Ghiciuc CM, Petrova G, Bitterman N, Kamberi F, Culig J, Wettermark B. European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement. Front Pharmacol. 2021 Oct 11;12:748702. doi: 10.3389/fphar.2021.748702. eCollection 2021. PMID: 34707502; PMCID: PMC8544003.
Copy Download .nbib Format: NLM
Positive and Negative Effects of Metal Oxide Nanoparticles on Antibiotic Resistance Genes Transfer.

Antibiotics (Basel, Switzerland)

Otinov GD, Lokteva AV, Petrova AD, Zinchenko IV, Isaeva MV, Kovtunov EA, Koshel EI.
PMID: 33121146
Antibiotics (Basel). 2020 Oct 27;9(11). doi: 10.3390/antibiotics9110742.

Rapid development of antibiotic resistance in bacteria is a critical public health problem in the world. One of the main routes of resistance development is the transfer of genes containing antibiotic resistance cassettes. Gene transfer can be done through...

Cite
Otinov GD, Lokteva AV, Petrova AD, et al. Positive and Negative Effects of Metal Oxide Nanoparticles on Antibiotic Resistance Genes Transfer. Antibiotics (Basel). 2020;9(11)doi: 10.3390/antibiotics9110742.
Otinov, G. D., Lokteva, A. V., Petrova, A. D., Zinchenko, I. V., Isaeva, M. V., Kovtunov, E. A., & Koshel, E. I. (2020). Positive and Negative Effects of Metal Oxide Nanoparticles on Antibiotic Resistance Genes Transfer. Antibiotics (Basel, Switzerland), 9(11), . https://doi.org/10.3390/antibiotics9110742
Otinov, Georgy D, et al. "Positive and Negative Effects of Metal Oxide Nanoparticles on Antibiotic Resistance Genes Transfer." Antibiotics (Basel, Switzerland) vol. 9,11 (2020). doi: https://doi.org/10.3390/antibiotics9110742
Otinov GD, Lokteva AV, Petrova AD, Zinchenko IV, Isaeva MV, Kovtunov EA, Koshel EI. Positive and Negative Effects of Metal Oxide Nanoparticles on Antibiotic Resistance Genes Transfer. Antibiotics (Basel). 2020 Oct 27;9(11). doi: 10.3390/antibiotics9110742. PMID: 33121146; PMCID: PMC7692205.
Copy Download .nbib Format: NLM
New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design.

International journal of molecular sciences

Kazakova O, Racoviceanu R, Petrova A, Mioc M, Militaru A, Udrescu L, Udrescu M, Voicu A, Cummings J, Robertson G, Ordway DJ, Slayden RA, Șoica C.
PMID: 34830423
Int J Mol Sci. 2021 Nov 21;22(22). doi: 10.3390/ijms222212542.

Twenty lupane type A-ring azepano-triterpenoids were synthesized from betulin and its related derivatives and their antitubercular activity against

Cite
Kazakova O, Racoviceanu R, Petrova A, et al. New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design. Int J Mol Sci. 2021;22(22)doi: 10.3390/ijms222212542.
Kazakova, O., Racoviceanu, R., Petrova, A., Mioc, M., Militaru, A., Udrescu, L., Udrescu, M., Voicu, A., Cummings, J., Robertson, G., Ordway, D. J., Slayden, R. A., & Șoica, C. (2021). New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design. International journal of molecular sciences, 22(22), . https://doi.org/10.3390/ijms222212542
Kazakova, Oxana, et al. "New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design." International journal of molecular sciences vol. 22,22 (2021). doi: https://doi.org/10.3390/ijms222212542
Kazakova O, Racoviceanu R, Petrova A, Mioc M, Militaru A, Udrescu L, Udrescu M, Voicu A, Cummings J, Robertson G, Ordway DJ, Slayden RA, Șoica C. New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design. Int J Mol Sci. 2021 Nov 21;22(22). doi: 10.3390/ijms222212542. PMID: 34830423; PMCID: PMC8621456.
Copy Download .nbib Format: NLM
[Role and place of cytologic diagnosis in clinical practice].

Klinicheskaia laboratornaia diagnostika

Petrova AS, Agamova KA, Ermolaeva AG.
PMID: 8963559
Klin Lab Diagn. 1996 Jul-Aug;(4):4-7.

No abstract available.

Cite
Petrova AS, Agamova KA, Ermolaeva AG. Rol' i mesto tsitologicheskoĭ diagnostiki v klinicheskoĭ praktike. [Role and place of cytologic diagnosis in clinical practice]. Klin Lab Diagn. 1996;(4):4-7
Petrova, A. S., Agamova, K. A., & Ermolaeva, A. G. (1996). Rol' i mesto tsitologicheskoĭ diagnostiki v klinicheskoĭ praktike. [Role and place of cytologic diagnosis in clinical practice]. Klinicheskaia laboratornaia diagnostika, (4), 4-7.
Petrova, A S, et al. "Rol' i mesto tsitologicheskoĭ diagnostiki v klinicheskoĭ praktike." [Role and place of cytologic diagnosis in clinical practice]. Klinicheskaia laboratornaia diagnostika vol. ,4 (1996): 4-7.
Petrova AS, Agamova KA, Ermolaeva AG. Rol' i mesto tsitologicheskoĭ diagnostiki v klinicheskoĭ praktike. [Role and place of cytologic diagnosis in clinical practice]. Klin Lab Diagn. 1996 Jul-Aug;(4):4-7. Russian. PMID: 8963559.
Copy Download .nbib Format: NLM
Correction to: Co-occurrence Networks Among Bacteria and Microbial Eukaryotes of Lake Baikal During a Spring Phytoplankton Bloom.

Microbial ecology

Mikhailov IS, Zakharova YR, Bukin YS, Galachyants YP, Petrova DP, Sakirko MV, Likhoshway YV.
PMID: 30610256
Microb Ecol. 2019 Feb;77(2):558. doi: 10.1007/s00248-018-1307-9.

The original version of this article unfortunately contained mistakes in the legends of figures.

Cite
Mikhailov IS, Zakharova YR, Bukin YS, et al. Correction to: Co-occurrence Networks Among Bacteria and Microbial Eukaryotes of Lake Baikal During a Spring Phytoplankton Bloom. Microb Ecol. 2019;77(2):558doi: 10.1007/s00248-018-1307-9.
Mikhailov, I. S., Zakharova, Y. R., Bukin, Y. S., Galachyants, Y. P., Petrova, D. P., Sakirko, M. V., & Likhoshway, Y. V. (2019). Correction to: Co-occurrence Networks Among Bacteria and Microbial Eukaryotes of Lake Baikal During a Spring Phytoplankton Bloom. Microbial ecology, 77(2), 558. https://doi.org/10.1007/s00248-018-1307-9
Mikhailov, Ivan S, et al. "Correction to: Co-occurrence Networks Among Bacteria and Microbial Eukaryotes of Lake Baikal During a Spring Phytoplankton Bloom." Microbial ecology vol. 77,2 (2019): 558. doi: https://doi.org/10.1007/s00248-018-1307-9
Mikhailov IS, Zakharova YR, Bukin YS, Galachyants YP, Petrova DP, Sakirko MV, Likhoshway YV. Correction to: Co-occurrence Networks Among Bacteria and Microbial Eukaryotes of Lake Baikal During a Spring Phytoplankton Bloom. Microb Ecol. 2019 Feb;77(2):558. doi: 10.1007/s00248-018-1307-9. PMID: 30610256.
Copy Download .nbib Format: NLM
Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria.

Frontiers in medicine

Dimitrova M, Pavlov K, Mitov K, Genov J, Petrova GI.
PMID: 28824914
Front Med (Lausanne). 2017 Aug 07;4:125. doi: 10.3389/fmed.2017.00125. eCollection 2017.

OBJECTIVE: HCV infection is a leading cause of chronic liver disease with long-term complications-extensive fibrosis, cirrhosis, and hepatocellular carcinoma. The objective of this study is to perform cost analysis of therapy of patients with chronic HCV-related cirrhosis hospitalized in...

Cite
Dimitrova M, Pavlov K, Mitov K, et al. Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria. Front Med (Lausanne). 2017;4:125doi: 10.3389/fmed.2017.00125.
Dimitrova, M., Pavlov, K., Mitov, K., Genov, J., & Petrova, G. I. (2017). Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria. Frontiers in medicine, 4125. https://doi.org/10.3389/fmed.2017.00125
Dimitrova, Maria, et al. "Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria." Frontiers in medicine vol. 4 (2017): 125. doi: https://doi.org/10.3389/fmed.2017.00125
Dimitrova M, Pavlov K, Mitov K, Genov J, Petrova GI. Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria. Front Med (Lausanne). 2017 Aug 07;4:125. doi: 10.3389/fmed.2017.00125. eCollection 2017. PMID: 28824914; PMCID: PMC5545579.
Copy Download .nbib Format: NLM
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.

Frontiers in public health

Godman B, Bucsics A, Vella Bonanno P, Oortwijn W, Rothe CC, Ferrario A, Bosselli S, Hill A, Martin AP, Simoens S, Kurdi A, Gad M, Gulbinovič J, Timoney A, Bochenek T, Salem A, Hoxha I, Sauermann R, Massele A, Guerra AA, Petrova G, Mitkova Z, Achniotou G, Laius O, Sermet C, Selke G, Kourafalos V, Yfantopoulos J, Magnusson E, Joppi R, Oluka M, Kwon HY, Jakupi A, Kalemeera F, Fadare JO, Melien O, Pomorski M, Wladysiuk M, Marković-Peković V, Mardare I, Meshkov D, Novakovic T, Fürst J, Tomek D, Zara C, Diogene E, Meyer JC, Malmström R, Wettermark B, Matsebula Z, Campbell S, Haycox A.
PMID: 30568938
Front Public Health. 2018 Dec 05;6:328. doi: 10.3389/fpubh.2018.00328. eCollection 2018.

No abstract available.

Cite
Godman B, Bucsics A, Vella Bonanno P, et al. Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. Front Public Health. 2018;6:328doi: 10.3389/fpubh.2018.00328.
Godman, B., Bucsics, A., Vella Bonanno, P., Oortwijn, W., Rothe, C. C., Ferrario, A., Bosselli, S., Hill, A., Martin, A. P., Simoens, S., Kurdi, A., Gad, M., Gulbinovič, J., Timoney, A., Bochenek, T., Salem, A., Hoxha, I., Sauermann, R., Massele, A., Guerra, A. A., Petrova, G., Mitkova, Z., Achniotou, G., Laius, O., Sermet, C., Selke, G., Kourafalos, V., Yfantopoulos, J., Magnusson, E., Joppi, R., Oluka, M., Kwon, H. Y., Jakupi, A., Kalemeera, F., Fadare, J. O., Melien, O., Pomorski, M., Wladysiuk, M., Marković-Peković, V., Mardare, I., Meshkov, D., Novakovic, T., Fürst, J., Tomek, D., Zara, C., Diogene, E., Meyer, J. C., Malmström, R., Wettermark, B., Matsebula, Z., Campbell, S., & Haycox, A. (2018). Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. Frontiers in public health, 6328. https://doi.org/10.3389/fpubh.2018.00328
Godman, Brian, et al. "Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets." Frontiers in public health vol. 6 (2018): 328. doi: https://doi.org/10.3389/fpubh.2018.00328
Godman B, Bucsics A, Vella Bonanno P, Oortwijn W, Rothe CC, Ferrario A, Bosselli S, Hill A, Martin AP, Simoens S, Kurdi A, Gad M, Gulbinovič J, Timoney A, Bochenek T, Salem A, Hoxha I, Sauermann R, Massele A, Guerra AA, Petrova G, Mitkova Z, Achniotou G, Laius O, Sermet C, Selke G, Kourafalos V, Yfantopoulos J, Magnusson E, Joppi R, Oluka M, Kwon HY, Jakupi A, Kalemeera F, Fadare JO, Melien O, Pomorski M, Wladysiuk M, Marković-Peković V, Mardare I, Meshkov D, Novakovic T, Fürst J, Tomek D, Zara C, Diogene E, Meyer JC, Malmström R, Wettermark B, Matsebula Z, Campbell S, Haycox A. Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. Front Public Health. 2018 Dec 05;6:328. doi: 10.3389/fpubh.2018.00328. eCollection 2018. PMID: 30568938; PMCID: PMC6290038.
Copy Download .nbib Format: NLM
Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries.

Frontiers in pharmacology

Malinowski KP, Kawalec P, Trąbka W, Czech M, Petrova G, Manova M, Savova A, Draganić P, Vostalová L, Slabý J, Männik A, Márky K, Rugaja Z, Gulbinovic J, Tesar T, Paveliu MS.
PMID: 31139080
Front Pharmacol. 2019 May 08;10:487. doi: 10.3389/fphar.2019.00487. eCollection 2019.

BACKGROUND: Reimbursement policies influence access of patients to orphan drugs in the European countries.OBJECTIVES: To provide a comprehensive description of orphan drug reimbursement policies and to assess reimbursement decision-making process in the EU-CEE countries as well as the impact...

Cite
Malinowski KP, Kawalec P, Trąbka W, et al. Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries. Front Pharmacol. 2019;10:487doi: 10.3389/fphar.2019.00487.
Malinowski, K. P., Kawalec, P., Trąbka, W., Czech, M., Petrova, G., Manova, M., Savova, A., Draganić, P., Vostalová, L., Slabý, J., Männik, A., Márky, K., Rugaja, Z., Gulbinovic, J., Tesar, T., & Paveliu, M. S. (2019). Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries. Frontiers in pharmacology, 10487. https://doi.org/10.3389/fphar.2019.00487
Malinowski, Krzysztof Piotr, et al. "Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries." Frontiers in pharmacology vol. 10 (2019): 487. doi: https://doi.org/10.3389/fphar.2019.00487
Malinowski KP, Kawalec P, Trąbka W, Czech M, Petrova G, Manova M, Savova A, Draganić P, Vostalová L, Slabý J, Männik A, Márky K, Rugaja Z, Gulbinovic J, Tesar T, Paveliu MS. Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries. Front Pharmacol. 2019 May 08;10:487. doi: 10.3389/fphar.2019.00487. eCollection 2019. PMID: 31139080; PMCID: PMC6518361.
Copy Download .nbib Format: NLM
Tri-, tetra-, and hexanuclear mixed-valence molybdenum clusters: structural diversity and catalysis of acetylene hydrogenation.

Dalton transactions (Cambridge, England : 2003)

Kuznetsov DA, Bazhenova TA, Fedyanin IV, Martynenko VM, Shestakov AF, Petrova GN, Komarova NS.
PMID: 27722482
Dalton Trans. 2016 Oct 18;45(41):16309-16316. doi: 10.1039/c6dt02965e.

A series of novel cluster compounds comprising molybdenum in a low valence state was synthesized by means of a disproportionation of the dimeric compound [Mo

Cite
Kuznetsov DA, Bazhenova TA, Fedyanin IV, et al. Tri-, tetra-, and hexanuclear mixed-valence molybdenum clusters: structural diversity and catalysis of acetylene hydrogenation. Dalton Trans. 2016;45(41):16309-16316doi: 10.1039/c6dt02965e.
Kuznetsov, D. A., Bazhenova, T. A., Fedyanin, I. V., Martynenko, V. M., Shestakov, A. F., Petrova, G. N., & Komarova, N. S. (2016). Tri-, tetra-, and hexanuclear mixed-valence molybdenum clusters: structural diversity and catalysis of acetylene hydrogenation. Dalton transactions (Cambridge, England : 2003), 45(41), 16309-16316. https://doi.org/10.1039/c6dt02965e
Kuznetsov, Denis A, et al. "Tri-, tetra-, and hexanuclear mixed-valence molybdenum clusters: structural diversity and catalysis of acetylene hydrogenation." Dalton transactions (Cambridge, England : 2003) vol. 45,41 (2016): 16309-16316. doi: https://doi.org/10.1039/c6dt02965e
Kuznetsov DA, Bazhenova TA, Fedyanin IV, Martynenko VM, Shestakov AF, Petrova GN, Komarova NS. Tri-, tetra-, and hexanuclear mixed-valence molybdenum clusters: structural diversity and catalysis of acetylene hydrogenation. Dalton Trans. 2016 Oct 18;45(41):16309-16316. doi: 10.1039/c6dt02965e. PMID: 27722482.
Copy Download .nbib Format: NLM
Risk factors for lung diseases after renal transplantation.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Pencheva VP, Petrova DS, Genov DK, Georgiev OB.
PMID: 26958045
J Res Med Sci. 2015 Dec;20(12):1127-32. doi: 10.4103/1735-1995.172978.

BACKGROUND: Lung diseases are one of the major causes of morbidity and mortality after renal transplantation. The aim of the study is to define the risk factors for infectious and noninfectious pulmonary complications in kidney transplant patients.MATERIALS AND METHODS:...

Cite
Pencheva VP, Petrova DS, Genov DK, et al. Risk factors for lung diseases after renal transplantation. J Res Med Sci. 2015;20(12):1127-32doi: 10.4103/1735-1995.172978.
Pencheva, V. P., Petrova, D. S., Genov, D. K., & Georgiev, O. B. (2015). Risk factors for lung diseases after renal transplantation. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 20(12), 1127-32. https://doi.org/10.4103/1735-1995.172978
Pencheva, Ventsislava P, et al. "Risk factors for lung diseases after renal transplantation." Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 20,12 (2015): 1127-32. doi: https://doi.org/10.4103/1735-1995.172978
Pencheva VP, Petrova DS, Genov DK, Georgiev OB. Risk factors for lung diseases after renal transplantation. J Res Med Sci. 2015 Dec;20(12):1127-32. doi: 10.4103/1735-1995.172978. PMID: 26958045; PMCID: PMC4766817.
Copy Download .nbib Format: NLM
Lost heat capacity and entropy in the helical magnet MnSi.

Physical review letters

Stishov SM, Petrova AE, Shikov AA, Lograsso TA, Isaev EI, Johansson B, Daemen LL.
PMID: 21231488
Phys Rev Lett. 2010 Dec 03;105(23):236403. doi: 10.1103/PhysRevLett.105.236403. Epub 2010 Dec 02.

The heat capacity of MnSi at B = 0 and B = 4 T was measured in the temperature range 2.5-100 K. To analyze the data, calculations of the phonon spectrum and phonon density of states in MnSi were...

Cite
Stishov SM, Petrova AE, Shikov AA, et al. Lost heat capacity and entropy in the helical magnet MnSi. Phys Rev Lett. 2010;105(23):236403doi: 10.1103/PhysRevLett.105.236403.
Stishov, S. M., Petrova, A. E., Shikov, A. A., Lograsso, T. A., Isaev, E. I., Johansson, B., & Daemen, L. L. (2010). Lost heat capacity and entropy in the helical magnet MnSi. Physical review letters, 105(23), 236403. https://doi.org/10.1103/PhysRevLett.105.236403
Stishov, Sergei M, et al. "Lost heat capacity and entropy in the helical magnet MnSi." Physical review letters vol. 105,23 (2010): 236403. doi: https://doi.org/10.1103/PhysRevLett.105.236403
Stishov SM, Petrova AE, Shikov AA, Lograsso TA, Isaev EI, Johansson B, Daemen LL. Lost heat capacity and entropy in the helical magnet MnSi. Phys Rev Lett. 2010 Dec 03;105(23):236403. doi: 10.1103/PhysRevLett.105.236403. Epub 2010 Dec 02. PMID: 21231488.
Copy Download .nbib Format: NLM
GC-MS studies of the chemical composition of two inedible mushrooms of the genus Agaricus.

Chemistry Central journal

Petrova A, Alipieva K, Kostadinova E, Antonova D, Lacheva M, Gjosheva M, Popov S, Bankova V.
PMID: 18096035
Chem Cent J. 2007 Dec 20;1:33. doi: 10.1186/1752-153X-1-33.

BACKGROUND: Mushrooms in the genus Agaricus have worldwide distribution and include the economically important species A. bisporus. Some Agaricus species are inedible, including A. placomyces and A. pseudopratensis, which are similar in appearance to certain edible species, yet are...

Cite
Petrova A, Alipieva K, Kostadinova E, et al. GC-MS studies of the chemical composition of two inedible mushrooms of the genus Agaricus. Chem Cent J. 2007;1:33doi: 10.1186/1752-153X-1-33.
Petrova, A., Alipieva, K., Kostadinova, E., Antonova, D., Lacheva, M., Gjosheva, M., Popov, S., & Bankova, V. (2007). GC-MS studies of the chemical composition of two inedible mushrooms of the genus Agaricus. Chemistry Central journal, 133. https://doi.org/10.1186/1752-153X-1-33
Petrova, Assya, et al. "GC-MS studies of the chemical composition of two inedible mushrooms of the genus Agaricus." Chemistry Central journal vol. 1 (2007): 33. doi: https://doi.org/10.1186/1752-153X-1-33
Petrova A, Alipieva K, Kostadinova E, Antonova D, Lacheva M, Gjosheva M, Popov S, Bankova V. GC-MS studies of the chemical composition of two inedible mushrooms of the genus Agaricus. Chem Cent J. 2007 Dec 20;1:33. doi: 10.1186/1752-153X-1-33. PMID: 18096035; PMCID: PMC2228291.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 151 entries